Evidence map›Paper›PMID 40249520›Full record

ArticleCellular and molecular life sciences : CMLS2025

Nano-encapsulated senolytic cocktail attenuates germ cell senescence in female mice.

Yiting Guan, Shuyue Deng, Xiaopeng Zou, Wenlu Wei, Zechen Li, Jiajing Zhong, Yanmei Zhu, Donghui Zhang, Yanmin Ju, Qing-Yuan Sun and 1 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Unleashing endogenous regeneration by senolytics.Journal of translational medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yiting Guan *Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Shuyue Deng *College of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
Xiaopeng Zou *Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Wenlu Wei *Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Zechen LiPrecision Clinical Laboratory, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Jiajing ZhongDepartment of Reproductive Health and Infertility, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Yanmei ZhuZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Donghui ZhangZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China.
Yanmin JuCollege of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
Qing-Yuan SunGuangzhou Key Laboratory of Metabolic Diseases and Reproductive Health, Guangdong-Hong Kong Metabolism & Reproduction Joint Laboratory, Reproductive Medicine Center, Guangdong Second Provincial General Hospital, Guangzhou, 518025, People's Republic of China.
Hongyong ZhangZhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, 524045, People's Republic of China. zhanghongyong13@mails.ucas.ac.cn.ORCID http://orcid.org/0000-0001-5585-1206

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2022A1515011702Basic and Applied Basic Research Foundation of Guangdong Province 2022A1515111164Basic and Applied Basic Research Foundation of Guangdong Province 2024A1515012916National Natural Science Foundation of China 82201715National Natural Science Foundation of China 82301863
6 · The paper itself

Abstract

Low-quality oocytes directly affect fertilization and embryonic development, contributing to infertility in women, while germ cell senescence leads to reduced germ cell numbers and decreased egg quality. Dasatinib and quercetin (D and Q), as senolytic drugs, have been extensively explored in different age-related diseases. However, their effects on in vitro cultured senescent oocytes and the molecular mechanisms underpinning ovarian aging remain elusive. Here, we report that a nano-encapsulated senolytic D + Q cocktail efficiently improves the quality of post-ovulatory aging oocyte in vitro and follicle quantity in ovaries in a cyclophosphamide (Cy)-induced premature ovarian failure (POF) mouse model. Cocktail supplementation to cultured oocytes potently reduces reactive oxygen species (ROS) levels, maintains spindle integrity, decreases fragmented oocyte frequencies, rescues mislocalized cortical granules (CGs) and mitochondrial membrane potential (MMP), and alleviates DNA damage and apoptosis. Importantly, the cocktail effectively ameliorates fertility deficits in the model. Transcriptome analysis shows cocktail administration to fertility-deficient mice not only up-regulates developmental gene expression but also reduces senescence-associated secretory phenotype (SASP) accumulation. Therefore, our nano-encapsulated D + Q cocktail is a promising reagent for assisted reproductive technology and improving reproductive outcomes in POF.

Indexed as

Cellular SenescenceOocytesPrimary Ovarian InsufficiencyQuercetinSenotherapeuticsAnimalsApoptosisCyclophosphamideDNA DamageFemaleMembrane Potential, MitochondrialMiceMice, Inbred C57BLReactive Oxygen SpeciesSenescence-Associated Secretory PhenotypeCyclophosphamideQuercetinReactive Oxygen SpeciesSenotherapeuticsInduced premature ovarian failureMitochondrial membrane potentialNano-encapsulated dasatinib and quercetin senolytic cocktailROSSenescence-associated secretory phenotype

Identifiers

PMID40249520
PMCPMC12008094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.